血清Cyfra21—1、CEA、NSE监测肺癌骨转移的临床意义
2015-01-06韩亮
韩亮
【摘 要】 目的:通过对肺癌患者肿瘤标志物骨胶素-细胞角蛋白19片段(Cyfra21-1)、癌胚抗原(CEA)、神经元特异性烯醇化酶(NSE)水平的测定,探讨肺癌骨转移患者血清Cyfra21-1、CEA、NSE水平变化,并评价其监测肺癌骨转移的临床意义。方法:对101例经病理或穿刺活检证实为肺癌的患者行99m锝-亚甲基二磷酸盐(99mTc-MDP)全身骨显像,根据骨转移诊断标准将肺癌患者分为未转移组(52例)、单发骨转移组(19例)、多发骨转移组(30例),同时对101例肺癌患者及30例肺部良性疾病患者进行血清Cyfra21-1、CEA、NSE水平测定,比较各组间血清Cyfra21-1、CEA、NSE水平的变化,并通过受试者工作特征曲线(Receiver operator characteristic curve,ROC曲线)评价其监测肺癌骨转移的准确性。结果:肺癌组血清Cyfra21-1、CEA、NSE水平明显高于肺部良性病变组(P<0.01);肺癌骨转移组血清Cyfra21-1、CEA、NSE水平明显高于未转移组(P<0.01),其中多发骨转移组明显高于单发骨转移组(P<0.05);血清Cyfra21-1、CEA、NSE的曲线下面积(Area under the ROC curves,AUC)分别为0.767、0.850、0.813,血清Cyfra21-1和CEA的敏感度最高,均为91.80%,血清NSE的特异度最高,为73.10%。结论:血清Cyfra21-1、CEA、NSE可作为肺癌骨转移的初筛及监测方法。
【关键词】 肺癌;骨转移;血清肿瘤标志物;ROC曲线
【中图分类号】R730.4 【文献标志码】 A 【文章编号】1007-8517(2014)15-0031-03
The change of serum Cyfra21-1, CEA, NSE levels in bone metastases
of lung cancer and its evaluation of accuracy
HAN Liang
(Thoracic Surgery, The Third Affiliated Hospital of Liaoning Medical College, Jinzhou City, Liaoning Province,121000 China)
Abstract:Objective To explore the change of serum Cyfra21-1、CEA、NSE levels in different degrees of bone metastases of lung cancer and evaluation of accuracy in diagnosing bone metastasis by mensuring the level of soluble fragment Cyfra21-1 of cytokeratin 19(CK19), carcinoembryonic antigen(CEA)and neuronspecific enolase(NSE). Methods 101 lung cancer patients confirmed by pathology or needle biopsy were underwent whole body bone images, and divided into without bone metastases(52 persons),single-bone metastases(19 persons) and multiplt-bone metastases(30 persons) groups according to the different degrees of bone metastasis. We detected the levels of serum Cyfra21-1、CEA、NSE of 101 patients and 30 lung benign disease patients and compared the change of tumor makerslevel in each group, evaluation of accuracy in diagnosing bone metastasis by receiver operating characteristic curve. Results The level of serum Cyfra21-1、CEA、NSE in lung cancer group were much higher than lung benign disease(P<0.01),the level of serum Cyfra21-1、CEA、NSE in lung cancer with bone metastasis group were much higher than without bone metastasis (P<0.01),and multiplt-bone metastases were much higher than single-bone metastases (P<0.05), The area under the curve of surem Cyfra21-1、CEA 、NSE were 0.767, 0.850, 0.813, The serum Cyfra21-1 and CEA had the highest sensitivity that is 91.8%, the serum NSE of the highest specificity, 73.10%.Conclusion Serum Cyfra21-1, CEA, NSE has a higher accuracy in diagnosing bone metastasis of lung cancer, and can be used as a method in screening and monitoring bone metastasis.
Keywords:Lung cancer; Osseous metastasis; Tumor markers; Receiver operator characteristic curve
肺癌为当前世界各地最常见的恶性肿瘤之一,是一种严重威胁人类健康及生命的疾病。在多数发达国家中,肺癌居男性恶性肿瘤首位,在女性中占第二位。肺癌患者易发生骨转移[1,2],因此早期发现骨转移对患者的分期、治疗、预后均有重要的临床意义。99m锝-亚甲基二磷酸盐(99mTc-MDP)全身骨显像虽是诊断骨转移的有效方法,但因其有放射性、对检查设施要求高、检查设备昂贵等在多数医院较难普及,因此寻找一种简便、快捷的初筛骨转移、监测骨转移的方法显得尤为重要。血清骨胶素-细胞角蛋白19片段(Cyfra21-1)、癌胚抗原(CEA)、神经元特异性烯醇化酶(NSE)是诊断肺癌常用的、敏感度较好的肿瘤标志物[3,4],本文拟通过对其水平测定,探讨肺癌骨转移患者血清肿瘤标志物水平的变化,并评价其诊断肺癌骨转移的准确性。……
